147
Participants
Start Date
March 31, 2006
Primary Completion Date
September 30, 2014
Study Completion Date
October 31, 2014
erlotinib hydrochloride
given orally
gemcitabine hydrochloride
given IV
Rex Cancer Center at Rex Hospital, Raleigh
Batte Cancer Center at Northeast Medical Center, Concord
Summit Cancer Care, Savannah
Kingsport Hematology-Oncology Associates, Kingsport
University of Tennessee Cancer Institute - Memphis, Memphis
Highlands Oncology Group - Fayetteville, Fayetteville
Evanston Hospital, Evanston
Hackensack University Medical Center Cancer Center, Hackensack
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
Blumenthal Cancer Center at Carolinas Medical Center, Charlotte
Cape Fear Valley Medical Center Cancer Center, Fayetteville
National Cancer Institute (NCI)
NIH
UNC Lineberger Comprehensive Cancer Center
OTHER